The WACC of Acceleron Pharma Inc (XLRN) is 6.9%.
| Range | Selected | |
| Cost of equity | 7.30% - 10.40% | 8.85% |
| Tax rate | -% - -% | -% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 6.1% - 7.7% | 6.9% |
| Category | Low | High |
| Long-term bond rate | 3.2% | 3.7% |
| Equity market risk premium | 4.2% | 5.2% |
| Adjusted beta | 0.97 | 1.18 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.30% | 10.40% |
| Tax rate | -% | -% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 6.1% | 7.7% |
| Selected WACC | 6.9% | |